BFRI
BFRI
NASDAQ · Pharmaceuticals

Biofrontera Inc

$0.81
+0.00 (+0.41%)
As of Mar 25, 5:40 PM ET ·
Financial Highlights (FY 2026)
Revenue
83.30M
Net Income
-39,641,119
Gross Margin
50.1%
Profit Margin
-47.6%
Rev Growth
+15.7%
D/E Ratio
0.92
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 50.1% 50.1% 59.5% 59.5%
Operating Margin -47.0% -42.3% 39.9% 36.7%
Profit Margin -47.6% -45.2% 28.1% 33.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 83.30M 72.01M 1.67M 1.59M
Gross Profit 41.77M 36.10M 993.6K 946.5K
Operating Income -39,120,010 -30,433,061 666.0K 584.8K
Net Income -39,641,119 -30,838,453 470.0K 528.6K
Gross Margin 50.1% 50.1% 59.5% 59.5%
Operating Margin -47.0% -42.3% 39.9% 36.7%
Profit Margin -47.6% -45.2% 28.1% 33.2%
Rev Growth +15.7% +15.7% +24.3% +24.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 2.39M 2.39M 868.4K 1.11M
Total Equity 2.59M 2.59M 5.54M 6.06M
D/E Ratio 0.92 0.92 0.16 0.18
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -34,811,882 -28,586,124 856.8K 789.7K
Free Cash Flow 585.2K 384.5K